XWPHARMA
XWPharma is a neuroscience biotech company that is researching new medicines for sleep, neuropsychiatric, and other neglected CNS illnesses. Bay Area, CA US.
XWPHARMA
Social Links:
Industry:
Biopharma Biotechnology Neuroscience
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.xwpharma.com
Total Employee:
11+
Status:
Active
Current Employees Featured
Official Site Inspections
http://www.xwpharma.com
- Host name: a20b9ee60132ef283.awsglobalaccelerator.com
- IP address: 13.248.155.104
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "XWPharma"
XWPharma - Crunchbase Company Profile & Funding
XWPharma is a neuroscience biotech company that is researching new medicines for sleep, neuropsychiatric, and other neglected CNS illnesses.See details»
XWPharma Company Profile 2024: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for XWPharma. Use the PitchBook Platform to explore the full profile.See details»
XWPharma - LinkedIn
XWPharma Biotechnology Bay Area, CA 1,076 followers Neuroscience biotech developing novel therapeutics for sleep, neuropsych, and other underserved CNS disorders.See details»
XWPharma - Funding, Financials, Valuation & Investors
XWPharma is a neuroscience biotech company that is researching new medicines for sleep, neuropsychiatric, and other neglected CNS illnesses.See details»
XWPharma Announces $40 Million Financing and Appoints …
REDWOOD CITY, Calif. and WUHAN, China, Sept. 17, 2020 (GLOBE NEWSWIRE) -- XWPharma (formerly XW Laboratories), a biopharmaceutical company dedicated to the …See details»
XWPharma - Contacts, Employees, Board Members, Advisors
XWPharma is a neuroscience biotech company that is researching new medicines for sleep, neuropsychiatric, and other neglected CNS illnesses.See details»
XWPharma Company Profile - Office Locations, Competitors, …
XWPharma has 5 employees across 2 locations and $57.5 m in total funding,. See insights on XWPharma including office locations, competitors, revenue, financials, executives, …See details»
XWPharma Initiates First-in-Human Studies of XW10508, in …
REDWOOD CITY, Calif. and WUHAN, China, Sept. 08, 2021 (GLOBE NEWSWIRE) -- XWPharma Ltd. today announced dosing of subjects in its first-in-human study evaluating …See details»
XWPharma Names Michael M. Morrissey, PhD to Board of Directors
Dec 16, 2020 “Joining XWPharma at this stage and playing a part in its future growth is very exciting for me,” added Dr. Morrissey. “The company has assembled an organization with …See details»
XWPharma Announces $40 Million Financing and Appoints …
Sep 17, 2020 Additional Capital Enables Advancement of Novel, Internally-Discovered Neuroscience Programs in Clinical Development Company Builds its Development and …See details»
XWPharma Announces $40 Million Financing and Appoints
Sep 17, 2020 XWPharma (formerly XW Laboratories) is a biopharmaceutical company dedicated to the discovery and development of therapeutics that apply novel platform …See details»
XWPharma Initiates First-in-Human Studies of XW10508, in …
Oct 18, 2021 Avance Clinical's client XWPharma Ltd. has announced dosing of subjects in its first-in-human study evaluating XW10508, the Company’s novel, patented, glutamatergic …See details»
XWPharma Names Michael M. Morrissey, PhD
REDWOOD CITY, Calif. and WUHAN, China, Dec. 16, 2020 (GLOBE NEWSWIRE) -- XWPharma Ltd. today announced that Michael M. Morrissey, Ph.D. has been appointed to the company’s …See details»
XWPharma Initiates First-in-Human Studies of XW10508, in …
REDWOOD CITY, Calif. and WUHAN, China, Sept. 08, 2021 (GLOBE NEWSWIRE) -- XWPharma Ltd. today announced dosing of subjects in its first-in-human study evaluating …See details»
XWPharma Announces Positive Results from Phase 1 Clinical Trials …
Jun 14, 2021 XWPharma is a biopharmaceutical company dedicated to the discovery and development of novel therapeutics, utilizing its proprietary platform chemistry. XWPharma's …See details»
XWPharma Names Glen Giovannetti to Board of Directors
REDWOOD CITY, Calif. and WUHAN, China, Feb 25, 2021 (GLOBE NEWSWIRE) – XWPharma Ltd. today announced that Glen Giovannetti has been appointed to the company’s Board of …See details»
XWPharma Announces Positive Results from Phase 1 Clinical
Jun 14, 2021 XWPharma's expertise in drug design is focused on providing potential first- and best-in-class medicines with differentiated features to address the unmet medical needs of …See details»
FDA Grants Orphan Drug Designation to XW Laboratories' XWL
WUHAN, China, June 24, 2019 /PRNewswire/ -- XW Laboratories Inc. (XW Labs), a clinical-stage biopharmaceutical company pioneering the discovery of novel small molecule therapeutics for …See details»
XWPharma Announces Positive Results from Phase 1 Clinical Trials …
REDWOOD CITY, CA and WUHAN, China, June 13, 2021 (GLOBE NEWSWIRE) – XWPharma Ltd. today announced that XW10172, an internally discovered, novel, patented conjugate of …See details»